Naftopidil

Naftopidil has been investigated for the treatment of Disorder of Urinary Stent. It is grouped under the following drug class(es): Alpha-1 Blockers. Its therapeutic use is listed as urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Flivas, Naftopidilum and 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol. Its PubChem CID is 4418.

CAS No 57149-07-2
Molecular Formula C24H28N2O3
Molecular Weight 392.5 g/mol
Synonyms 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol

Frequently Asked Questions